About
Dr. Ananthu S Manoj is a physician and healthcare technology founder based in Kerala, India.
He is Founder and Designated Partner of NeuroHue Therapeutics
LLP, a digital health company building clinical technology for
neurodevelopmental care — assessment, therapy monitoring, and
interpretation tools used by institutions, clinicians, therapists
and families.
Work on the underlying systems began in 2021. NeuroHue Therapeutics
was formally incorporated in 2026, once the approach had been
tested in practice. Its systems are now operational across multiple
institutions in India, with a pilot deployment underway in Malaysia
adapted to different clinical structures.
01
Background
Ananthu S Manoj trained in medicine at Vydehi Institute of Medical
Sciences and Research Centre.
His approach to building clinical technology comes from practice
rather than from software. The problems NeuroHue Therapeutics
addresses were encountered in clinical settings first, and the
systems are designed around how developmental care is actually
delivered rather than how it is described.
02
NeuroHue Therapeutics
The company builds structured assessment and therapy-monitoring
systems for neurodevelopmental care. Three patent applications have
been filed in India, covering neurodevelopmental assessment
methodology, therapy monitoring, and data-driven clinical systems.
The work sits between three things that rarely meet: clinical
practice, developmental science, and the design of systems
clinicians will actually use in the room.
Deployment partners are not named publicly. Clinical institutions
work under confidentiality, and that is respected here.
03
Current work
His work spans neurodevelopmental care, digital therapeutics,
clinical analytics, machine learning in healthcare, and clinical
workflow design.
He is currently developing healthcare-focused foundational models
and building structured clinical and behavioural datasets intended
to support the training and evaluation of artificial intelligence
systems in medicine — an area where the shortage of well-structured
clinical data is a greater constraint than model capability.
04
Research
Alongside the company's clinical systems, he maintains an ongoing
programme of exploratory research into behavioural interpretation,
developmental signal analysis, and the interpretive frameworks
underlying developmental assessment.
This research is early-stage and distinct from the deployed
systems.